The role of synovial fluid cytokines IL-6, IL-23 and IL-17 in the pathogenesis and persistence of synovial inflammation in JIA patients

Documenti analoghi

• Impact of a 2-yr anti-TNF treatment on the quality of life in JIA patients: a parent's/patient’s view
  di: Diafa, K, et al.
  Pubblicazione: (2011)
• The use of Etanercept and Adalimumab in the management of JIA: a 5-year follow-up study
  di: Trachana, M, et al.
  Pubblicazione: (2008)
• The portrait of Familial Mediterranean Fever in N. Greek pediatric patients: a 30-year experience
  di: Pratsidou-Gertsi, P, et al.
  Pubblicazione: (2015)
• B lymphocyte stimulator, interferon-α and HMGB 1 interrelation in childhood onset systemic lupus erythematosus: associations with disease activity and severity
  di: Kanakoudi-Tsakalidou, Florence, et al.
  Pubblicazione: (2014)
• PReS-FINAL-2093: Can clinical response within 12 weeks in JIA-etanercept receivers predict the future clinical remission?
  di: Pratsidou-Gertsi, P, et al.
  Pubblicazione: (2013)